Volume 329, Issue 12 pp. 554-555
Note
Full Access

3-Hydroxymethylphenytoin Valproic Acid Ester, a New Prodrug Combining Two Anticonvulsant Drugs

Gerhard K. E. Scriba

Gerhard K. E. Scriba

Department of Pharmaceutical Chemistry, University of Münster, Hittorfstrasse 58–62, D-48149 Münster, Germany

Search for more papers by this author
First published: 1996
Citations: 5

Dedicated to Prof. Dr. Gerhard Rücker on the occasion of his 65th birthday.

Abstract

3-Hydroxymethylphenytoin valproic acid ester (VAL-PHT) was designed as a new prodrug combining valproic acid and phenytoin, two anticonvulsant drugs with different pharmacological profiles. The compound was hydrolyzed by rat plasma esterases in vitro but exhibited only activity in the maximal electroshock seizure test (MES test) after intraperitoneal administration to mice. The compound did not protect against pentylenetetrazole-induced seizures. It is concluded that VAL-PHT acts as a prodrug displaying the anticonvulsant profile of phenytoin.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.